Evidence map›Paper›PMID 37649777›Full record

ArticleOxford open neuroscience2023

A Critical Review of Zebrafish Neurological Disease Models-1. The Premise: Neuroanatomical, Cellular and Genetic Homology and Experimental Tractability.

Harold A Burgess, Edward A Burton

Open access · diamondAbstract read
In one paragraph

Article in Oxford open neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Zebrafish: A Versatile and Powerful Model for Biomedical Research.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Zebrafish models of human-duplicatedbioRxiv : the preprint server for biology · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Harold A BurgessDivision of Developmental Biology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, 20892, USA.ORCID https://orcid.org/0000-0003-1966-7801
Edward A BurtonPittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh, Pittsburgh, PA, 15260, USA.ORCID https://orcid.org/0000-0002-8072-4636
Eunice Kennedy Shriver National Institute of Child Health and Human Development · USUniversity of Pittsburgh · US

Funding

Pathogenic mechanisms of gene-environment interactions in Parkinson's diseaseR01ES022644 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BURTON, EDWARD ALAN · 2014 to 2018
$1.7M
ROS driven mitochondrial-telomere dysfunction during environmental stressR33ES025606 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI OPRESKO, PATRICIA L, VAN HOUTEN, BENNETT · 2017 to 2019
$1.6M
A Phenotype-Optimized Zebrafish Model of Progressive Supranuclear PalsyR33NS125280 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BURTON, EDWARD ALAN, SCHOPPIK, DAVID · 2023 to 2024
$531k
A Phenotype-Optimized Zebrafish Model of Progressive Supranuclear PalsyR61NS125280 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BURTON, EDWARD ALAN, SCHOPPIK, DAVID · 2022 to 2022
$497k
Functional evaluation of genes adjacent to risk-modulating SNPs in the pathogenesis of PSPR21NS123211 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BURTON, EDWARD ALAN · 2021 to 2021
$434k
Development of Zebrafish Taupoathy Models for Translational ResearchR21NS080881 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BURTON, EDWARD ALAN · 2013 to 2014
$419k
ROS driven mitochondrial-telomere dysfunction during environmental stressR21ES025606 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI OPRESKO, PATRICIA L, VAN HOUTEN, BENNETT · 2015 to 2016
$414k
Role of BET proteins in neuroinflammation in tauopathyI01BX003168 · VA · VETERANS HEALTH ADMINISTRATION · PI Edward Alan Burton · 2017 to 2026
–
BLRD VA I01 BX003168NIEHS NIH HHS R01 ES022644NIEHS NIH HHS R21 ES025606NIEHS NIH HHS R33 ES025606NINDS NIH HHS R21 NS080881NINDS NIH HHS R21 NS123211NINDS NIH HHS R33 NS125280NINDS NIH HHS R61 NS125280
6 · The paper itself

Abstract

The last decade has seen a dramatic rise in the number of genes linked to neurological disorders, necessitating new models to explore underlying mechanisms and to test potential therapies. Over a similar period, many laboratories adopted zebrafish as a tractable model for studying brain development, defining neural circuits and performing chemical screens. Here we discuss strengths and limitations of using the zebrafish system to model neurological disorders. The underlying premise for many disease models is the high degree of homology between human and zebrafish genes, coupled with the conserved vertebrate Bauplan and repertoire of neurochemical signaling molecules. Yet, we caution that important evolutionary divergences often limit the extent to which human symptoms can be modeled meaningfully in zebrafish. We outline advances in genetic technologies that allow human mutations to be reproduced faithfully in zebrafish. Together with methods that visualize the development and function of neuronal pathways at the single cell level, there is now an unprecedented opportunity to understand how disease-associated genetic changes disrupt neural circuits, a level of analysis that is ideally suited to uncovering pathogenic changes in human brain disorders.

Indexed as

CRISPRdisease modelsneural developmentneuroanatomytransgenicszebrafish

Identifiers

PMID37649777
PMCPMC10464506
OpenAlexW4313813443

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.